Latest News
IceCure reports growing adoption of ProSense cryoablation in Brazil
6 July 2026 - Cryoablation technology company IceCure Medical (NASDAQ: ICCM) reported on Monday that commercial adoption and physician interest in its ProSense cryoablation system are increasing in Brazil following its recent US FDA clearance for the...
PharmaEssentia secures Health Canada approval for BESREMi in polycythaemia vera
6 July 2026 - Taiwan-based biopharmaceutical company PharmaEssentia (TWSE: 6446) announced on Monday that its subsidiary FORUS Therapeutics has received a Notice of Compliance from Health Canada for BESREMi (ropeginterferon alfa-2b) for the treatment...
Aurinia initiates PRESERVE Phase 4 study of LUPKYNIS combination therapy in lupus nephritis
6 July 2026 - Biopharmaceutical company Aurinia Pharmaceuticals (NASDAQ: AUPH) declared on Monday that it has initiated the PRESERVE Phase 4, multicentre study evaluating LUPKYNIS in combination with belimumab, obinutuzumab or anifrolumab in patients...
Anixa Biosciences advances ovarian cancer CAR-T trial to highest dose level
...
Insulet expands European footprint with Omnipod 5 and Omnipod Discover launch in Spain
6 July 2026 - Medical device company Insulet Corporation (NASDAQ:PODD) announced on Monday the launch of its Omnipod 5 Automated Insulin Delivery System and Omnipod Discover data platform in Spain, marking its 26th country of commercialisation and th...